|
TOP NEWS
Blue Shield Still Facing Therapy 'Ghost Network' Suit
By Bonnie Eslinger
A California federal judge ruled Wednesday that Blue Shield of California must face the majority of claims brought in subscribers' proposed class action alleging the insurer maintained a "ghost network" of mental-health providers that didn't exist or accept new patients, saying the suit adequately claims contract terms were not met.
Order attached |
Read full article »
| Save to favorites »
ENFORCEMENT & COMPLIANCE
LITIGATION
Vein Tech Maker Escapes Suit Over DOJ Kickback Probe
By Katryna Perera
A New York federal judge has tossed, for now, a proposed investor class action alleging that vein disease device maker Inari Medical Inc.'s share price fell after it disclosed an investigation into its compliance with federal anti-kickback laws, finding the suit does not plausibly show Inari was paying healthcare providers unlawful kickbacks, among other things.
Order attached |
Read full article »
| Save to favorites »
Organ Network Says Kidney Race Bias Claims Can't Proceed
By Rachel Riley
The United Network for Organ Sharing is seeking to exit a proposed class action claiming it prolonged wait times for Black patients seeking kidney transplants by encouraging hospitals to use a flawed race-based adjustment when measuring kidney function, saying the network's policy was "silent" as to how such scores were calculated.
2 documents attached |
Read full article »
| Save to favorites »
MERGERS & ACQUISITIONS
PEOPLE
EXPERT ANALYSIS
Teva, Wyeth Show How Claimed Advances Shape Enablement
Two recent Federal Circuit decisions involving method-of-treatment claims — Teva v. Eli Lilly and Wyeth v. AstraZeneca — reached opposite enablement outcomes from strikingly similar procedural postures, but a closer comparison of the cases reveals a three-step framework for understanding the court's reasoning, says Kendall Gurule at Polsinelli.
2 documents attached |
Read full article »
| Save to favorites »
LEGAL INDUSTRY
|